DSC-PWI影像组学特征提升成人弥漫性胶质瘤分子亚型三分类预测
本研究纳入272例成人弥漫性胶质瘤患者,从常规MRI和DSC-PWI分别提取1197个影像组学特征,构建三分类随机森林模型预测IDHwt、IDHmut-noncodel和IDHmut-codel分子亚型。验证集显示,多模态影像组学模型在预测IDHwt和IDHmut-codel亚型上优于常规MRI模型,与结合临床指标的联合模型性能相似。结论:在常规MRI基础上加入DSC-PWI可改善弥漫性胶质瘤分子亚型预测。
要点
- DSC-PWI影像组学特征可提升IDHwt和IDHmut-codel亚型的预测性能。
- 多模态模型与联合临床指标的模型性能相似,提示影像组学可独立贡献。
- T1增强和rCBV图像的影像组学特征在分子亚型预测中起重要作用。
核心结论
- 在常规MRI基础上加入DSC-PWI影像组学特征,可改善成人弥漫性胶质瘤IDHwt和IDHmut-codel分子亚型的预测,且多模态模型性能与联合临床指标的模型相似。
研究设计与样本
- 单中心回顾性研究,纳入272例II-IV级成人弥漫性胶质瘤患者(训练集166例,验证集106例;平均年龄48.7岁,范围19-77岁)。
- 从常规MRI和DSC-PWI每个序列分别提取1197个影像组学特征,采用Boruta算法筛选特征,构建三分类随机森林模型。
- 参考标准为分子亚型分类:IDHwt、IDHmut-noncodel和IDHmut-codel;验证集用于比较模型AUC。
关键影像表现/征象
- 共筛选19个影像组学特征(13个来自常规MRI,6个来自DSC-PWI)构建多模态影像组学模型。
- T1加权钆增强和相对脑血容量(rCBV)图像的影像组学特征在分子亚型预测中起重要作用。
诊断标准与关键数值
- 验证集中,多模态影像组学模型预测IDHwt和IDHmut-codel亚型的性能优于常规影像组学模型,预测IDHmut-noncodel亚型的性能与常规模型相当。
- 多模态影像组学模型预测三种分子亚型的性能与联合模型(影像组学+临床指标)相似。
临床应用与阅片要点
- 对于成人弥漫性胶质瘤,在常规MRI报告中可关注T1增强和rCBV图像的影像组学特征,辅助提示IDHwt和1p/19q编码缺失亚型。
- 多模态模型与联合模型性能相似,提示影像组学特征可独立提供分子亚型信息,减少对临床指标的依赖。
局限性
- 单中心回顾性研究,样本量有限(共272例),需外部多中心验证。
- 研究未报告敏感度、特异度、AUC具体数值及置信区间,无法评估精确诊断性能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate whether radiomic features extracted from dynamic susceptibility contrast perfusion-weighted imaging (DSC-PWI) can improve the prediction of the molecular subtypes of adult diffuse gliomas, and to further develop and validate a multimodal radiomic model by integrating radiomic features from conventional and perfusion MRI.
METHODS: We extracted 1197 radiomic features from each sequence of conventional MRI and DSC-PWI, respectively. The Boruta algorithm was used for feature selection and combination, and a three-class random forest method was applied to construct the models. We also constructed a combined model by integrating radiomic features and clinical metrics. The models' diagnostic performance for discriminating the molecular subtypes (IDH wild type [IDHwt], IDH mutant and 1p/19q-noncodeleted [IDHmut-noncodel], and IDH mutant and 1p/19q-codeleted [IDHmut-codel]) was compared using AUCs in the validation set.
RESULTS: We included 272 patients (training set, n = 166; validation set, n = 106) with grade II-IV gliomas (mean age, 48.7 years; range, 19-77 years). The proportions of the molecular subtypes were 66.2% IDHwt, 15.1% IDHmut-noncodel, and 18.8% IDHmut-codel. Nineteen radiomic features (13 from conventional MRI and 6 from DSC-PWI) were selected to build the multimodal radiomic model. In the validation set, the multimodal radiomic model showed better performance than the conventional radiomic model did in predicting the IDHwt and IDHmut-codel subtypes, which was comparable to the conventional radiomic model in predicting the IDHmut-noncodel subtype. The multimodal radiomic model yielded similar performance as the combined model in predicting the three molecular subtypes.
CONCLUSIONS: Adding DSC-PWI to conventional MRI can improve molecular subtype prediction in patients with diffuse gliomas.
KEY POINTS: • The multimodal radiomic model outperformed conventional MRI when predicting both the IDH wild type and IDH mutant and 1p/19q-codeleted subtypes of gliomas. • The multimodal radiomic model showed comparable performance to the combined model in the prediction of the three molecular subtypes. • Radiomic features from T1-weighted gadolinium contrast-enhanced and relative cerebral blood volume images played an important role in the prediction of molecular subtypes.
引用
- Pei, Guan, Hong, et al. Radiomic features from dynamic susceptibility contrast perfusion-weighted imaging improve the three-class prediction of molecular subtypes in patients with adult diffuse gliomas. Eur Radiol. 2023. PMID: 36853347. doi:10.1007/s00330-023-09459-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。